Bone Tissue Engineering With Chitosan, Carbon Nanotubes, and Hydroxyapatite Biomaterials Enriched With Mesenchymal Stem Cells: A Radiographic and Histological Evaluation in a Sheep Model Undergoing Ostectomy (Bone Tissue Engineering in a Sheep Model)
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2025
DOI: 10.1002/jbm.b.35523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2025. Verfasst von Geissiane de Moraes Marcondes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Veterinary Medicine and Animal Science, University of São Paulo (FMVZ-USP), São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Chitosan, Durapatite, Nanotubes, Carbon, Tissue Engineering. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Comminuted fractures associated with tissue loss can adversely affect bone regeneration. Biomaterials enriched with mesenchymal stem cells (MSCs) employed for supporting osteosynthesis and potentiating osteoconduction are necessary to fill these bone defects. Natural compound biomaterials, similar to bone tissue, have been extensively tested in animal models for clinical use. Bone tissue engineering studies have used critical‐size defects in ovine tibia monitored by imaging and histological examinations to evaluate the regenerative process. This study aimed to monitor the regenerative process in ovine tibial defects with or without chitosan, carbon nanotubes, or hydroxyapatite biomaterials, enriched or not enriched with MSCs. A 3‐cm ostectomy was performed in 18 female Suffolk sheep. A 10‐hole 4.5 mm narrow locking compression plate was used for osteosynthesis. The animals were randomly divided into three groups ( n = 6): control (CON); defects filled with chitosan, carbon nanotubes, and hydroxyapatite biomaterial (BIO); and the same biomaterial enriched with bone marrow MSCs (BIO + CELL). The animals were evaluated monthly using radiographic examinations until 90 postoperative days, when they were euthanized. The limbs were subjected to micro‐computed tomography (micro‐CT), and bone specimens were subjected to histological evaluations. The radiographic examinations revealed construction stability without plate deviation, fracture, or bone lysis. Micro‐CT evaluation demonstrated a difference in bone microarchitecture between the CON and biomaterial treatment groups (BIO and BIO + CELL). In the histological evaluations, the CON group did not demonstrate bone formation, and in the treatment groups (BIO and BIO + CELL), biocompatibility with sheep tissue was noted, and bone formation with trabeculae interspersed with remnants of the biomaterial was observed, with no differences between the groups. In conclusion, biomaterials present osteoconduction with beneficial characteristics for filling bone‐lost fractures, and MSCs did not interfere with bone formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, School of Veterinary Medicine and Animal Science, University of São Paulo (FMVZ-USP), São Paulo, SP, Brazil.
- Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo (FMVZ-USP), São Paulo, SP, Brazil.
- Department of Stomatology, School of Dentistry, University of São Paulo (FO-USP), São Paulo, SP, Brazil.
- Department of Oral Biology, School of Dentistry, University of São Paulo (FO-USP), São Paulo, SP, Brazil.
- Department of Chemistry and Molecular Physics, Institute of Chemistry of São Carlos, University of São Paulo (IQSC-USP), São Carlos, SP, Brazil.
ORCID-Profile: Geissiane de Moraes Marcondes, Nicole Fidalgo Paretsis, Danielle Cristinne Baccarelli da Silva, Anderson Fernando de Souza, Mario Antônio Ferraro Rego, Grazieli Cristina Monteiro da Silva, Joice Fülber, Luciana Corrêa, Simone Peixe Friedrichsdorf, Ana Maria de Guzzi Plepis, Virginia da Conceição Amaro Martins, Silvia Renata Gaido Cortopassi, André Luis do Valle De Zoppa
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
de Moraes Marcondes, G., Paretsis, N. F., da Silva, D. C. B., de Souza, A. F., Rego, M. A. F., da Silva, G. C. M., Fülber, J., Corrêa, L., Friedrichsdorf, S. P., de Guzzi Plepis, A. M., da Conceição Amaro Martins, V., Cortopassi, S. R. G., & do Valle De Zoppa, A. L. (2025). Bone Tissue Engineering With Chitosan, Carbon Nanotubes, and Hydroxyapatite Biomaterials Enriched With Mesenchymal Stem Cells: A Radiographic and Histological Evaluation in a Sheep Model Undergoing Ostectomy (Bone Tissue Engineering in a Sheep Model). Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35523
Vancouver
de Moraes Marcondes G, Paretsis NF, da Silva DCB, de Souza AF, Rego MAF, da Silva GCM, et al. Bone Tissue Engineering With Chitosan, Carbon Nanotubes, and Hydroxyapatite Biomaterials Enriched With Mesenchymal Stem Cells: A Radiographic and Histological Evaluation in a Sheep Model Undergoing Ostectomy (Bone Tissue Engineering in a Sheep Model). Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2025. doi:10.1002/jbm.b.35523
BibTeX
@article{deMoraesMarcondes2025,
author = {de Moraes Marcondes, Geissiane and Paretsis, Nicole Fidalgo and da Silva, Danielle Cristinne Baccarelli and de Souza, Anderson Fernando and Rego, Mario Antônio Ferraro and da Silva, Grazieli Cristina Monteiro and Fülber, Joice and Corrêa, Luciana and Friedrichsdorf, Simone Peixe and de Guzzi Plepis, Ana Maria and da Conceição Amaro Martins, Virginia and Cortopassi, Silvia Renata Gaido and do Valle De Zoppa, André Luis},
title = {Bone Tissue Engineering With Chitosan, Carbon Nanotubes, and Hydroxyapatite Biomaterials Enriched With Mesenchymal Stem Cells: A Radiographic and Histological Evaluation in a Sheep Model Undergoing Ostectomy (Bone Tissue Engineering in a Sheep Model)},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2025},
doi = {10.1002/jbm.b.35523}
}
EUVIMED